國立高雄大學圖資館 |

語系: 繁體中文

說明(常見問題)

圖資館首頁

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

High-density lipoproteins as biomark...

Cho, Kyung-Hyun.

High-density lipoproteins as biomarkers and therapeutic tools.Volume 1,Impacts of lifestyle, diseases, and environmental stressors on HDL

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	High-density lipoproteins as biomarkers and therapeutic tools.by Kyung-Hyun Cho.
其他題名:	Impacts of lifestyle, diseases, and environmental stressors on HDL
作者:	Cho, Kyung-Hyun.
出版者:	Singapore :Springer Singapore :2019.
面頁冊數:	xxiv, 383 p. :ill., digital ;24 cm.
Contained By:	Springer eBooks
標題:	High density lipoproteins.
電子資源:	https://doi.org/10.1007/978-981-13-7387-9
ISBN:	9789811373879$q(electronic bk.)

High-density lipoproteins as biomarkers and therapeutic tools.Volume 1,Impacts of lifestyle, diseases, and environmental stressors on HDL
Cho, Kyung-Hyun.

High-density lipoproteins as biomarkers and therapeutic tools.Volume 1,Impacts of lifestyle, diseases, and environmental stressors on HDL[electronic resource] /Impacts of lifestyle, diseases, and environmental stressors on HDLby Kyung-Hyun Cho. - Singapore :Springer Singapore :2019. - xxiv, 383 p. :ill., digital ;24 cm.

Preface -- Chapter 1. Understanding HDL: overview -- 1-1.HDL and disease -- 1-2.HDL functions and clinical applications -- 1-3.HDL composition : apolipoproteins and enzymes -- 1-4.Maturation of HDL -- 1-5.HDL and blood pressure -- Chapter 2. Change of HDL by life style -- 2-1.Exercise and HDL -- 2-2.Smoking and HDL -- 2-3.Elderly's HDL -- 2-4.HDL depends on body weight -- 2-5.HDL from obese but healthy subject -- 2-6.HDL and apoA-I in smokers' breast milk -- 2-7.Breast milk from frequent trans fatty acid consumers -- 2-8.HDL in cord blood from small neonates -- Chapter 3. Change of HDL in various diseases -- 3-1.HDL from patients with myocardial infarction -- 3-2.HDL from patients with female angina pectoris -- 3-3.HDL and metabolic syndrome -- 3-4.HDL from male patients with atrial fibrillation -- 3-5.HDL from female patients with atrial fibrillation -- 3-6.HDL from patients with hemorrhagic fever with renal syndrome -- 3-7.HDL from patients with rheumatoid arthritis -- 3-8.HDL and prehypertension -- Chapter 4. Detriment of HDL by pollutant and its evaluation -- 4-1.Particulate matter and HDL -- 4-2.Phthalate and HDL -- 4-3.Cadmium and HDL -- 4-4.Humidifier Sterilizer and HDL -- 4-5.Detection of dysfunctional HDL by microfluidics -- 4-6.Evaluation of dysfunctional HDL using zebrafish embryo -- Chapter 5. Change of HDL by food ingredient -- 5-1.Fructose and apoA-I -- 5-2.Fructose and impairment of HDL functionality -- 5-3.Artificial sweeteners and apoA-I -- 5-4.Artificial sweeteners (aspartame, saccharin) and HDL -- 5-5.Aldoketohexoses and HDL -- 5-6.Iron and HDL -- 5-7.Trans fat and HDL -- 5-8.Salt and HDL 576 p -- Summary and perspectives.

This book is the first of two volumes that offer a comprehensive, up-to-date account of current knowledge regarding high-density lipoprotein (HDL), the changes that occur in HDL under different conditions, the clinical applications of HDL, and means of enhancing HDL functionality. HDL comprises a diverse group of lipoproteins and its composition and metabolism are dynamic. In this volume, the focus is on the changes observed in HDL under different health statuses, with particular attention to the functional and structural correlations of HDL and apolipoprotein A-1. The impacts of a wide variety of factors on HDL are examined in depth, covering, for example, diet, exercise, smoking, age, diverse diseases, and different forms of environmental pollution. It has long been known that HDL has anti-atherosclerotic and antidiabetic properties, and more recently its anti-aging activities have been recognized. These benefits of HDL are highly dependent on its lipids, proteins, apolipoproteins, and enzymes, and specifically their composition and ratios. In documenting the latest knowledge in this field, this volume will be of interest to both researchers and clinicians.

ISBN: 9789811373879$q(electronic bk.)

Standard No.: 10.1007/978-981-13-7387-9doiSubjects--Topical Terms:

486208
High density lipoproteins.

LC Class. No.: QP99.3.H53 / C465 2019

Dewey Class. No.: 572.68

High-density lipoproteins as biomarkers and therapeutic tools.Volume 1,Impacts of lifestyle, diseases, and environmental stressors on HDL
LDR:04029nmm a2200349 a 4500 001 558578
003 DE-He213
005 20191016145422.0
006 m d
007 cr nn 008maaau
008 191219s2019 si s 0 eng d
020 $a 9789811373879$q(electronic bk.)
020 $a 9789811373862$q(paper)
024 7 $a 10.1007/978-981-13-7387-9 $2 doi
035 $a 978-981-13-7387-9
040 $a GP $c GP
041 0 $a eng
050 4 $a QP99.3.H53 $b C465 2019
072 7 $a MBGR $2 bicssc
072 7 $a SCI049000 $2 bisacsh
072 7 $a MBGR $2 thema
072 7 $a PSD $2 thema
082 0 4 $a 572.68 $2 23
090 $a QP99.3.H53 $b C545 2019
100 1 $a Cho, Kyung-Hyun. $3 841282
245 1 0 $a High-density lipoproteins as biomarkers and therapeutic tools. $n Volume 1, $p Impacts of lifestyle, diseases, and environmental stressors on HDL $h [electronic resource] / $c by Kyung-Hyun Cho.
246 3 0 $a Impacts of lifestyle, diseases, and environmental stressors on HDL
260 $a Singapore : $b Springer Singapore : $b Imprint: Springer, $c 2019.
300 $a xxiv, 383 p. : $b ill., digital ; $c 24 cm.
505 0 $a Preface -- Chapter 1. Understanding HDL: overview -- 1-1.HDL and disease -- 1-2.HDL functions and clinical applications -- 1-3.HDL composition : apolipoproteins and enzymes -- 1-4.Maturation of HDL -- 1-5.HDL and blood pressure -- Chapter 2. Change of HDL by life style -- 2-1.Exercise and HDL -- 2-2.Smoking and HDL -- 2-3.Elderly's HDL -- 2-4.HDL depends on body weight -- 2-5.HDL from obese but healthy subject -- 2-6.HDL and apoA-I in smokers' breast milk -- 2-7.Breast milk from frequent trans fatty acid consumers -- 2-8.HDL in cord blood from small neonates -- Chapter 3. Change of HDL in various diseases -- 3-1.HDL from patients with myocardial infarction -- 3-2.HDL from patients with female angina pectoris -- 3-3.HDL and metabolic syndrome -- 3-4.HDL from male patients with atrial fibrillation -- 3-5.HDL from female patients with atrial fibrillation -- 3-6.HDL from patients with hemorrhagic fever with renal syndrome -- 3-7.HDL from patients with rheumatoid arthritis -- 3-8.HDL and prehypertension -- Chapter 4. Detriment of HDL by pollutant and its evaluation -- 4-1.Particulate matter and HDL -- 4-2.Phthalate and HDL -- 4-3.Cadmium and HDL -- 4-4.Humidifier Sterilizer and HDL -- 4-5.Detection of dysfunctional HDL by microfluidics -- 4-6.Evaluation of dysfunctional HDL using zebrafish embryo -- Chapter 5. Change of HDL by food ingredient -- 5-1.Fructose and apoA-I -- 5-2.Fructose and impairment of HDL functionality -- 5-3.Artificial sweeteners and apoA-I -- 5-4.Artificial sweeteners (aspartame, saccharin) and HDL -- 5-5.Aldoketohexoses and HDL -- 5-6.Iron and HDL -- 5-7.Trans fat and HDL -- 5-8.Salt and HDL 576 p -- Summary and perspectives.
520 $a This book is the first of two volumes that offer a comprehensive, up-to-date account of current knowledge regarding high-density lipoprotein (HDL), the changes that occur in HDL under different conditions, the clinical applications of HDL, and means of enhancing HDL functionality. HDL comprises a diverse group of lipoproteins and its composition and metabolism are dynamic. In this volume, the focus is on the changes observed in HDL under different health statuses, with particular attention to the functional and structural correlations of HDL and apolipoprotein A-1. The impacts of a wide variety of factors on HDL are examined in depth, covering, for example, diet, exercise, smoking, age, diverse diseases, and different forms of environmental pollution. It has long been known that HDL has anti-atherosclerotic and antidiabetic properties, and more recently its anti-aging activities have been recognized. These benefits of HDL are highly dependent on its lipids, proteins, apolipoproteins, and enzymes, and specifically their composition and ratios. In documenting the latest knowledge in this field, this volume will be of interest to both researchers and clinicians.
650 0 $a High density lipoproteins. $3 486208
650 1 4 $a Molecular Medicine. $3 273932
650 2 4 $a Pharmaceutical Sciences/Technology. $3 338426
650 2 4 $a Biomedical Engineering/Biotechnology. $3 730838
650 2 4 $a Diabetes. $3 274215
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer eBooks
856 4 0 $u https://doi.org/10.1007/978-981-13-7387-9
950 $a Biomedical and Life Sciences (Springer-11642)